EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools

Giulio Corrivetti, Francesco Monaco iD, Annarita Vignapiano iD, Alessandra Marenna, Kaia Palm, Salvador Fernández-Arroyo iD, Eva Frigola-Capell iD, Volker Leen, Oihane Ibarrola iD, Burak Amil iD, Mattia Marco Caruson, Lorenzo Chiariotti und 6 weitere

Brain Sciences · 28.06.2024 · 14 (7) · 658

DOI: 10.3390/brainsci14070658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 28.06.2024. Verfasst von Giulio Corrivetti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health, Azienda Sanitaria Locale Salerno, 84123 Salerno, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the World Health Organization (WHO), major depressive disorder (MDD) is the fourth leading cause of disability worldwide and the second most common disease after cardiovascular events. Approximately 280 million people live with MDD, with incidence varying by age and gender (female to male ratio of approximately 2:1). Although a variety of antidepressants are available for the different forms of MDD, there is still a high degree of individual variability in response and tolerability. Given the complexity and clinical heterogeneity of these disorders, a shift from “canonical treatment” to personalized medicine with improved patient stratification is needed. OPADE is a non-profit study that researches biomarkers in MDD to tailor personalized drug treatments, integrating genetics, epigenetics, microbiome, immune response, and clinical data for analysis. A total of 350 patients between 14 and 50 years will be recruited in 6 Countries (Italy, Colombia, Spain, The Netherlands, Turkey) for 24 months. Real-time electroencephalogram (EEG) and patient cognitive assessment will be correlated with biological sample analysis. A patient empowerment tool will be deployed to ensure patient commitment and to translate patient stories into data. The resulting data will be used to train the artificial intelligence/machine learning (AI/ML) predictive tool.

Schlagwörter

Stichwörter der Autor:innen

EEGartificial intelligencechatbotgeneticsinflammationmajor depressive disordersmetabolomicmicrobiomepersonalized medicinetranscriptomics

Autor:innen und Institutionen

  • Department of Mental Health, Azienda Sanitaria Locale Salerno, 84123 Salerno, Italy.
  • European Biomedical Research Institute of Salerno (EBRIS), 84125 Salerno, Italy.
  • Protobios, 12618 Tallinn, Estonia.
  • Centre for Omic Sciences, Joint Unit Eurecat Technological Centre of Catalonia-Rovira i Virgili University, Unique Scientific and Technical Infrastructure (ICTS), 43204 Reus, Spain.
  • Mental Health Research Group, Institut d'Investigació Biomèdica de Girona-CERCA, 17190 Girona, Spain.
  • Mental Health and Addictions Network, Institut Assistència Sanitària (IAS), 17190 Girona, Spain.

ORCID-Profile: Francesco Monaco, Annarita Vignapiano, Salvador Fernández-Arroyo, Eva Frigola-Capell, Oihane Ibarrola, Burak Amil

Förderung

  • European Commission

Zitieren

APA

Corrivetti, G., Monaco, F., Vignapiano, A., Marenna, A., Palm, K., Fernández-Arroyo, S., Frigola-Capell, E., Leen, V., Ibarrola, O., Amil, B., Caruson, M. M., Chiariotti, L., Palacios-Ariza, M. A., Hoekstra, P. J., Chiang, H. Y., Floareș, A., Fagiolini, A., & Fasano, A. (2024). Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools. Brain Sciences, 14(7), 658. https://doi.org/10.3390/brainsci14070658

Vancouver

Corrivetti G, Monaco F, Vignapiano A, Marenna A, Palm K, Fernández-Arroyo S, et al. Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools. Brain Sciences. 2024;14(7):658. doi:10.3390/brainsci14070658

BibTeX
@article{Corrivetti2024,
  author = {Corrivetti, Giulio and Monaco, Francesco and Vignapiano, Annarita and Marenna, Alessandra and Palm, Kaia and Fernández-Arroyo, Salvador and Frigola-Capell, Eva and Leen, Volker and Ibarrola, Oihane and Amil, Burak and Caruson, Mattia Marco and Chiariotti, Lorenzo and Palacios-Ariza, Maria Alejandra and Hoekstra, Pieter J and Chiang, Hsin-Yin and Floareș, Alexandru and Fagiolini, Andrea and Fasano, Alessio},
  title = {Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools},
  journal = {Brain Sciences},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {658},
  doi = {10.3390/brainsci14070658}
}
Kostenlos starten →